Recursion Pharmaceuticals News - August 4, 2026

🟢 Recursion Pharmaceuticals is trading 5% up today ahead of Q2 earnings and a broader biotech rally

Recursion Pharmaceuticals is trading 5% up at $3.35 as investors position themselves ahead of the company's second-quarter results scheduled for August 5,...

Recursion Pharmaceuticals Inc Q2 2026 Earnings Preview: What Analysts Expect on August 05, 2026

Analysts expect Recursion Pharmaceuticals to report a Q2 2026 consensus revenue of $10.97 million and an EPS loss of $0.25, with the stock currently trading...